Navigation Links
Siragusa Vein and Vascular Center Publishes New Article to Raise Awareness for Arterial Disease Prevention
Date:8/26/2013

Nashville, TN (PRWEB) August 26, 2013

The Siragusa Vein and Vascular Center has produced an article describing the risk factors for vein disease. The Nashville-based vein center says that vein disease can affect anyone at any time, but that there are some risk factors that increase the incidence of this condition. They also detail alternative steps that everyone can take to maintain effectively functioning veins.

Dr. Tif Siragusa, a leading vein doctor at the Nashville’s Siragusa Vein and Vascular Center, affirms lifestyle changes are an effective way to maintain a high level of venous health. “People who are concerned about the health of their veins should take steps to exercise on a regular basis, manage their weight, and quit smoking. Obesity and smoking can both weaken the veins, while exercise helps to promote better blood flow.”

The article also urges those who already have vein disease to see a specialist for vein disease treatment. The Vein and Vascular Center has all of the tools required to diagnose and treat vein disease. They make recommendations based on what is best for each individual patient to manage vein disease at every stage.

Dr. Tif Siragusa and the staff of the Vein and Vascular Center hope that releasing this information to the public will encourage people to recognize their own risk for vein disease in order to take steps toward making preventive measures against the condition and to seek treatment when appropriate.

For more information, visit:
http://www.nashvilleveincenter.com/

About the Siragusa Vein and Vascular Center

The Siragusa Vein and Vascular Center is nationally recognized in venous therapies and comes highly recommended by many physicians. Dr. Siragusa, Director of the center, provides a personal, individualized approach to each patient based on their history of vascular problems, physical exam findings, as well as the detailed information gained by their Duplex Ultrasound.

Siragusa Vein and Vascular Center’s minimally invasive techniques eliminate the down time associated with surgical procedures of the past. Most patients drive themselves to the office and back home after treatments, avoiding the inconvenience of disrupting the schedules of family or friends. Moms can get back to taking care of the kids that day and most people are back to work the next day. As a specialist in vein treatment and vascular surgery, Dr. Siragusa also excels in the evaluation and treatment of other conditions including Carotid Artery Stenosis, Abdominal Aortic Aneurysms, Peripheral Vascular Disease, and Deep Vein Thrombosis.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11059156.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Siragusa Vein and Vascular Launches Health Campaign on Advanced Stages of Venous Disease
2. Pulse pressure elevation could presage cerebrovascular disease in Alzheimers patients
3. Original research papers on acute cardiovascular care: ESC launches EHJ-ACVC
4. Is it time for regional cardiovascular emergency care systems across the US?
5. New guidelines deliver concise messages for implementing cardiovascular prevention
6. Meditation practice may decrease risk for cardiovascular disease in teens
7. Meditation practice may decrease risk for cardiovascular disease in teens
8. Elsevier, SVS announce 2013 launch of Journal of Vascular Surgery: Venous and Lymphatic Disorders
9. Guidelines Issued for When Docs Should Order Vascular Testing
10. Exercise program improved health of lung transplant patients and cut cardiovascular risk
11. Low steroid levels linked to increased risk of cardiovascular disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... DC (PRWEB) , ... March 30, 2017 , ... ... and organizations submitted a letter to President Trump expressing their support for an ... medical doctors, two Ph.D. scientists and one medical journalist, will hold a press ...
(Date:3/29/2017)... ... March 29, 2017 , ... In the United States alone, up ... year develop other types of metastatic brain tumors(3). Though most meningiomas are benign, metastatic ... focus on finding more effective treatment options, the San Diego Gamma Knife Center ...
(Date:3/29/2017)... ... 2017 , ... Grass pollen is the main cause of hay fever in the United States, ... grass pollen runs from May to July each year; with the worst time for sufferers ... allergen barrier balms ( http://www.haymax.us ) provide an effective defense against grass pollen; they are ...
(Date:3/29/2017)... FL (PRWEB) , ... March 30, 2017 , ... Sublime ... the "Spice of Life" or "Wonder Spice", it has been used for thousands of ... in the East," says Heshelow, author of " Turmeric: How to Use it For ...
(Date:3/29/2017)... ... March 29, 2017 , ... AngioGenesis Labs ... store in Mississippi. AngioGenesis Labs, makers of HeartBoost, BrainBest and BeautyBest, achieved these ... Ingredients in HeartBoost, an over the counter heart healthy drink, can reduce Arterial ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... -- Wound care devices and products are used to ... industry mainly consists of establishments engaged in manufacturing wound ... caused by mechanical, chemical, thermal, and radiogenic trauma; and ... skin related diseases, immunological diseases, and other chronic diseases. ... largest region in the wound care devices market in ...
(Date:3/29/2017)... , March 29, 2017 Global intravenous (IV) iron ... billion by 2021, growing at a CAGR of 5%. ... by a doctor to treat anemia or other iron deficiencies. ... in the body. However, in some cases, oral administrations are ... and intravenous (IV) iron therapy comes into the picture. ...
(Date:3/29/2017)... N.J. , March 29, 2017  Novartis ... Administration (FDA) has accepted the company,s Biologics License ... CTL019 (tisagenlecleucel-T), an investigational chimeric antigen receptor T ... pediatric and young adult patients with B-cell acute ... submission by Novartis for a CAR-T. The priority ...
Breaking Medicine Technology: